MX3 Strengthens Trust with Major Compliance Achievements

MX3 Passes Data Security and Privacy Milestone with HIPAA and SOC 2 Type I Compliance

AUSTIN, Texas, Sept. 11, 2025 /PRNewswire/ — MX3 Diagnostics today announced that it has achieved full HIPAA (Health Insurance Portability and Accountability Act) and SOC 2 Type I compliance, reaffirming its dedication to safeguarding customer data while delivering cutting-edge digital health solutions.

HIPAA compliance ensures that MX3 adheres to strict federal regulations for the protection of sensitive health information. This includes maintaining rigorous safeguards around the storage, transmission, and use of personal medical data. By meeting HIPAA requirements, MX3 provides customers in healthcare, occupational safety, government, and elite performance environments with confidence that their data is secure, private, and handled with the highest level of care.

SOC 2 Type I compliance—developed by the American Institute of CPAs (AICPA)—is a key industry standard that evaluates an organization’s controls related to security, availability, confidentiality, and privacy at a specific point in time. This certification confirms that MX3 has implemented the necessary systems, policies, and procedures to ensure data is protected and managed responsibly from day one. It provides customers and partners assurance that MX3’s infrastructure and practices are designed with data security at their core.

“Protecting our customers’ personal information is just as important as providing accurate, real-time health insights,” said Michael Luther, CEO at MX3 Diagnostics. “Achieving HIPAA and SOC 2 Type I compliance ensures that every organization and individual who relies on MX3 can have complete trust in both our technology and our ability to keep their data safe.”

By meeting these critical standards, MX3 strengthens its role as a trusted partner to organizations that require secure, compliant, and scalable solutions for health and performance diagnostics. To learn more, visit www.mx3diagnostics.com.

Media Contact: Genevieve Gorgos, Director of Operations, genevieve@mx3diagnostics.com

About MX3 Diagnostics: 

MX3 Diagnostics is a digital health company that has pioneered portable saliva-based hydration testing systems for sports, military, and workplace safety. Founded in 2017 and based in Austin, TX, and Melbourne, Australia, MX3’s clinically validated biomarker tests and cloud analytics are deployed by hundreds of elite sports teams, Fortune 1000 companies, government agencies, and healthcare facilities around the world. MX3 customers have performed over 7 million tests using the company’s products to optimize personal health, safety, and performance.

View original content to download multimedia:https://www.prnewswire.com/news-releases/mx3-strengthens-trust-with-major-compliance-achievements-302554213.html

SOURCE MX3 Diagnostics, Inc.

Staff

Recent Posts

Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc.

North Bergen, New Jersey--(Newsfile Corp. - February 6, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN)…

2 minutes ago

Rare Element Resources Announces Commencement of Rights Offering to Purchase Common Shares

FIRESTONE, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to…

57 minutes ago

Alder Bowman appoints Kelly Quilliam to Launch Medical Technology Practice

Alder Bowman www.alderbowman.com is an executive search and consulting firm specializing in healthcare.NASHVILLE, Tenn.--(BUSINESS WIRE)--Healthcare…

58 minutes ago

Rural Health Transformation Funding Raises the Stakes for Rural Hospital Cash Flow as Revenue Cycle Outsourcing Demand Accelerates

Black Book poll of 162 rural hospital revenue cycle and business office leaders finds outsourcing…

1 hour ago

AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

Live video webcast on Wednesday, February 11th at 1:40 PM EST OCALA, Fla., Feb. 06,…

1 hour ago

Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium

AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck)…

1 hour ago